Table 3. Summary of the prescribed LLT and their relative intensities among T2DM subjects.

	Frequency (N)	Percent (%)
Status of the Prescribed LLT
No LLT	322	20.2
Simvastatin	1,084	67.8
Atorvastatin	120	7.5
Other Statin Monotherapy	7	0.4
Statin Combination Therapy	41	2.6
Non-statin Monotherapy	24	1.5
The intensity of the Prescribed Statin therapy
Low intensity	144	9
Moderate Intensity	1005	62.9
High Intensity	103	6.4
No Statin Therapy	346	21.7
	1,598	100.0